Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-24
2006-10-24
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S552000
Reexamination Certificate
active
07125864
ABSTRACT:
The present invention relates to compounds of formula (I): wherein variable groups are as defined within; pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidemia. Processes for their manufacture and pharmaceutical compositions containing them are also described
REFERENCES:
patent: 2002/0142054 (2002-10-01), Marlett et al.
patent: 19825804 (1999-12-01), None
patent: 0372542 (1990-06-01), None
patent: 0 864 582 (1998-09-01), None
patent: 2262888 (1993-07-01), None
patent: 93/16055 (1993-08-01), None
patent: 94/18183 (1994-08-01), None
patent: 94/18184 (1994-08-01), None
patent: 96/05188 (1996-02-01), None
patent: 96/08484 (1996-03-01), None
patent: 96/16051 (1996-05-01), None
patent: 97/33882 (1997-09-01), None
patent: 98/38182 (1998-09-01), None
patent: 98/40375 (1998-09-01), None
patent: 99/01149 (1999-01-01), None
patent: 99/32478 (1999-07-01), None
patent: 99/35135 (1999-07-01), None
patent: 99/64409 (1999-12-01), None
patent: 99/64410 (1999-12-01), None
patent: 00/01687 (2000-01-01), None
patent: 00/38725 (2000-07-01), None
patent: 00/38726 (2000-07-01), None
patent: 00/38727 (2000-07-01), None
patent: 00/38728 (2000-07-01), None
patent: 00/38729 (2000-07-01), None
patent: 00/47568 (2000-08-01), None
patent: 00/61568 (2000-10-01), None
patent: 00/62810 (2000-10-01), None
patent: 01/60807 (2001-08-01), None
patent: 01/66533 (2001-09-01), None
patent: 01/68096 (2001-09-01), None
patent: 01/68637 (2001-09-01), None
patent: 02/08211 (2002-01-01), None
patent: 02/32428 (2002-04-01), None
patent: 02/50051 (2002-06-01), None
patent: 02/053548 (2002-07-01), None
patent: 03/020710 (2003-03-01), None
patent: 03/022286 (2003-03-01), None
patent: 03/022830 (2003-03-01), None
patent: 03/061663 (2003-07-01), None
patent: 03/091232 (2003-11-01), None
patent: 03/106482 (2003-12-01), None
patent: 2004/006899 (2004-01-01), None
patent: 2004/076430 (2004-09-01), None
patent: 2004/089350 (2004-10-01), None
Govers et al., Journal of Lipid Research, 35(5), 1994, pp. 741-748.
Higaki et al., Arteriosclerosis, Thrombosis, and Vascular Biology, 18(8), 1998, pp. 1304-1311.
Ishibashi et al., Journal of Clinical Investigation, 92(2), 1993, pp. 883-893.
Lewis et al., Journal of Lipid Research, 36, 1995, pp. 1098-1105.
Plump et al., Cell, (71), 1992, pp. 343-353.
Schiller, Alimentary Pharmacology and Therapeutics, 15(6), 2001, pp. 749-763.
Sprong et al., J. Nutrition (US), 132(6), 2002, pp. 1269-1274.
Van'Tilburg et al., Gastroenterology, 98(1), 1989, pp. 25-32.
Welberg et al., Scandinavian J. Gastroenterology Suppl Norway, 188, 1991, pp. 52-59.
Blomberg David
Dahlstrom Mikael Ulf Johan
Starke Ingemar
AstraZeneca AB
Kifle Bruck
Morgan & Lewis & Bockius, LLP
LandOfFree
Benzothiazepine derivatives for the treatment of hyperlipidemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiazepine derivatives for the treatment of hyperlipidemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazepine derivatives for the treatment of hyperlipidemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642899